SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019172
Filing Date
2022-07-13
Accepted
2022-07-13 16:15:38
Documents
16
Period of Report
2022-07-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 66420
2 ex3-1.htm EX-3.1 2032
3 ex3-1_001.jpg GRAPHIC 595728
4 ex3-1_002.jpg GRAPHIC 216478
  Complete submission text file 0001493152-22-019172.txt   1422241

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE foxw-20220712.xsd EX-101.SCH 4069
6 XBRL DEFINITION FILE foxw-20220712_def.xml EX-101.DEF 27681
7 XBRL LABEL FILE foxw-20220712_lab.xml EX-101.LAB 38437
8 XBRL PRESENTATION FILE foxw-20220712_pre.xml EX-101.PRE 26298
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7318
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39891 | Film No.: 221081214
SIC: 2834 Pharmaceutical Preparations